findmyKOL
Clinical trialNCT06541847RecruitingPhase 2Interventional

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

SponsorHealx LimitedEnrollment25Neurofibromatosis Type 1
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

    Girish DhallLaura Katherine Metrock
    Recruiting
  • Children'S Hospital Los Angeles

    Los Angeles, California, United States

    Anat Erdreich-EpsteinAshley MargolKaaren WatersKasey RanganKatrina O'HalloranNathan RobisonSara-Jane OneyeamaTena RosserTom DavidsonVless Trinidad
    Recruiting
  • Stanford University

    Palo Alto, California, United States

    Cynthia CampenKatherine RyanPaul FisherSonia Partap
    Recruiting
  • Children'S Hospital Colorado

    Aurora, Colorado, United States

    Holly LindsayMolly HemenwayNicholas ForemanShelby Winzent-Oonk
    Recruiting
  • Children'S National Hospital

    Washington D.C., District of Columbia, United States

    AeRang KimAmy HontBenjamin SiegelBrian RoodEugene HwangHolly MeanyLindsay KilburnLiny JohnRoger Packer
    Recruiting
  • Ann & Robert H. Lurie Children'S Hospital of Chicago

    Chicago, Illinois, United States

    Alicia LenzenAngela WaandersAshley PlantMaggie SeblaniMiriam Bornhorst
    Recruiting
  • University of Chicago

    Chicago, Illinois, United States

    James TonsgardShawn Damodharan
    Recruiting
  • Indiana University

    Indianapolis, Indiana, United States

    Brian WeissJayne VonbergenKathryn NevelScott CovenSteven Rhodes
    Recruiting
  • Johns Hopkins Hospital

    Baltimore, Maryland, United States

    Carlos RomoJaishri BlakeleyKelly WypychShannon Langmead
    Recruiting
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Allison KingAmy ArmstrongAndrea OgleAndrew ClusterAngela HirbeAshley MeyerBrian Van TineBryan SiskCamille SkaerChristina CareyDaniel WillisDavid WilsonFrederick HuangLeslie GloverLinda GoldenbergLoren AbernathyMia WeissMohamed AbdelbakiMolly WarnerNicole BrossierSanita Burgic
    Recruiting
  • New York University Langone Health

    New York, New York, United States

    Devorah SegalJessica ClymerJordie BlumKaleb Yohay
    Recruiting
  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

    Aaron MochizukiBenjamin MizukawaChristine PhillipsEllen ChangErin BreeseJohn PerentesisJonathan BenderJoseph PresseyKaren BurnsLaQuita JonesLauren PommertLynn LeeNatasha Pillay-SmileyPeter De BlankRichard GrahamRobin NorrisThomas GallettaTrent Hummel
    Recruiting
  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

    Amish ShahCassie KlineChelsea KotchJane MinturnJean BelascoJessica FosterKristina ColeMichael FisherStephanie Brosius
    Recruiting
  • University of Texas Southwestern Medical Center

    Dallas, Texas, United States

    Alexis KennedyDaniel BowersDevon KnottsElizabeth MaherEvan NochJonathan WickiserJustin JordanLaura KlesseMichael Youssef
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Feb 2025
Primary completion
30 Jun 2027
Completion
31 Jan 2028
Last update posted
19 May 2026
Registered enrollment
25
Registry id
NCT06541847

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.